Article

Drug Interaction and Pharmacist

Ansari JA1★★ Corresponding author

  1. 1Department of Pharmacology, Faculty of Pharmacy, Hamdard University, New Delhi, INDIA.

CORRESPONDENCE

Ansari JA

Department of Pharmacology, Faculty of Pharmacy, Hamdard University, New Delhi, INDIA.

javed.ansari47@gmail.com

Volume 2, Issue 3 · pp. 326–331 · PUBLISHED · DOI: 10.4103/0975-1483.66807

View on JYP original site ↗

ABSTRACT

The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride, and 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors. The pharmacist, along with the prescriber has a duty to ensure that patients are aware of the risk of side effects and a suitable course of action should they occur. With their detailed knowledge of medicine, pharmacists have the ability to relate unexpected symptoms experienced by patients to possible adverse effects of their drug therapy.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    JA, A. (). Drug Interaction and Pharmacist. Journal of Young Pharmacists, 2(3), 326–331. https://doi.org/10.4103/0975-1483.66807